CARsgen Therapeutics' CAR-T therapy zevor-cel gains inclusion in China's 2025 Innovative Drug Catalogue, highlighting regulatory support and improved patient access for relapsed/refractory multiple myeloma treatment.

Comprehensive update on U.S. health insurance market dynamics including ACA subsidy uncertainty, Medicare specialty payment reforms, SNAP funding challenges, healthcare industry consolidations, pharmaceutical litigation, and emerging clinical innovations affecting insurance professionals.